(Total Views: 691)
Posted On: 06/04/2022 2:05:49 PM
Post# of 145246
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Goosebumps #124186
Dr. Mazen Noureddin will be presenting 2 posters at ILC 2022; #3410 for TERN-201 (AOC3 protein inhibitor), and #3924 for Leronlimab. Cedars-Sinai has 9 NASH/NAFLD trials at present, with a 10th hopefully in the near future.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)